Abstract: The present disclosure provides an apparatus and a method for hydrate-based wastewater treatment and cold storage. The apparatus for hydrate-based wastewater treatment and cold storage includes a water chilling unit, a hydrate-based cold storage tank, an airflow disturbance device, a water layer positioning system, a spraying system, a suction filtration system, a heat exchange system, and a system monitoring device. The water chilling unit provides a secondary refrigerant at a low temperature. The secondary refrigerant flows through an evaporator coil in the hydrate-based cold storage tank for heat exchange. The airflow disturbance device induces hydrate nucleation. The water layer positioning system positions a contact surface between a water layer and a hydrate former after hydrate decomposition to facilitate drawing and separation of the treated upper water layer. The spraying system and the suction filtration system enhance the solid-liquid separation efficiency to improve the removal rate of pollutants.

Abstract: The invention provides a method for preparing lithium manganese iron phosphate, which includes the following steps: S1: mixing a manganese source and/or an iron source in solid phase to obtain a first mixture; S2: sintering the first mixture in solid phase at 300° C. to 1200° C. to obtain a manganese iron oxide (MnxFe1?x?y)mOn; S3: mixing the manganese iron oxide (MnxFe1?x?y)mOn with a lithium source, a phosphorus source, and optionally a manganese source and/or an iron source in solid phase to obtain a second mixture; and S4: sintering the second mixture in solid phase at 350° C. to 900° C. to obtain lithium manganese iron phosphate LiMnxFe1?x?yPO4, wherein 0?x?1, and 0?y?1. The method of the present invention can be used to prepare a lithium manganese iron phosphate material with high tap density, long cycle life, low costs, and high cost-effectiveness.

Abstract: The preparation and use of systems to provide surrogate whole blood controls using coagulation modifiers to simulate human whole blood in coagulation assays are disclosed.